SCTX — Scribe Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Scribe Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS
Standards:	USG	USG
Status:	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	105	58
Net Total Accounts Receivable
Net Total Receivables	3.52	7.35
Prepaid Expenses
Total Current Assets	110	66.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.2	10.1
Other Long Term Assets
Total Assets	128	78.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35	69.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	133	101
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-5.5	-23.1
Total Liabilities & Shareholders' Equity	128	78.2
Total Common Shares Outstanding